• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外受精卵巢刺激后,用促性腺激素释放激素类似物刺激内源性促黄体生成素激增。

Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in vitro fertilization.

作者信息

Imoedemhe D A, Sigue A B, Pacpaco E L, Olazo A B

机构信息

Human Reproductive Biology Unit, Soliman Fakeeh Hospital, Jeedah, Saudi Arabia.

出版信息

Fertil Steril. 1991 Feb;55(2):328-32. doi: 10.1016/s0015-0282(16)54125-9.

DOI:10.1016/s0015-0282(16)54125-9
PMID:1899396
Abstract

The effect of induction of preovulatory endogenous surge of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) with intranasal administration of GnRH-analog (GnRH-a) in an in vitro fertilization (IVF) program is reported. The use of GnRH-a resulted in a significantly better percentage of replaceable embryos (91% versus 85%). The pregnancy rate was 51% in comparison with 32% in control cycles in which follicular maturation was achieved by human chorionic gonadotropin administration. There was no significant difference in the postoocyte recovery serum progesterone patterns between the two groups. Our results indicate that the induction of endogenous LH and FSH surge with GnRH-a may be successfully employed for final follicular maturation after ovarian suprastimulation without affecting the outcome of IVF adversely. Apart from being a more physiological approach to oocyte maturation, it also has potential economic and clinical advantages.

摘要

本文报道了在体外受精(IVF)程序中,经鼻给予促性腺激素释放激素类似物(GnRH-a)诱导促黄体生成素(LH)和促卵泡生成素(FSH)排卵前内源性高峰的效果。使用GnRH-a后,可移植胚胎的百分比显著提高(91%对85%)。妊娠率为51%,而通过注射人绒毛膜促性腺激素实现卵泡成熟的对照周期妊娠率为32%。两组在取卵后血清孕酮模式上无显著差异。我们的结果表明,使用GnRH-a诱导内源性LH和FSH高峰可成功用于卵巢超刺激后的最终卵泡成熟,且不会对IVF结果产生不利影响。除了是一种更符合生理的卵母细胞成熟方法外,它还具有潜在的经济和临床优势。

相似文献

1
Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in vitro fertilization.体外受精卵巢刺激后,用促性腺激素释放激素类似物刺激内源性促黄体生成素激增。
Fertil Steril. 1991 Feb;55(2):328-32. doi: 10.1016/s0015-0282(16)54125-9.
2
Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.在接受重组促卵泡激素和促性腺激素释放激素(GnRH)拮抗剂联合治疗进行卵巢刺激后的体外受精患者中,给予重组人绒毛膜促性腺激素、重组促黄体生成素或GnRH激动剂诱导最终卵母细胞成熟后,未补充黄体期的特征。
J Clin Endocrinol Metab. 2003 Sep;88(9):4186-92. doi: 10.1210/jc.2002-021953.
3
[Comparison of a long-acting and short-acting GnRH analog in combination with gonadotropins in in vitro fertilization under various indications].[长效与短效促性腺激素释放激素类似物联合促性腺激素在不同适应证体外受精中的比较]
Geburtshilfe Frauenheilkd. 1989 Feb;49 Suppl 1:85-90. doi: 10.1055/s-2008-1026585.
4
Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication.在接受辅助生殖卵巢刺激的女性中,使用单剂量促性腺激素释放激素(GnRH)激动剂曲普瑞林在GnRH拮抗剂加尼瑞克治疗后触发排卵,特别提及预防卵巢过度刺激综合征:初步报告:简短通讯
Hum Reprod. 2000 Sep;15(9):1965-8. doi: 10.1093/humrep/15.9.1965.
5
Endocrine composition of follicular fluid comparing human chorionic gonadotrophin to a gonadotrophin-releasing hormone agonist for ovulation induction.比较人绒毛膜促性腺激素与促性腺激素释放激素激动剂用于诱导排卵时卵泡液的内分泌成分
Hum Reprod. 1993 Jun;8(6):840-3. doi: 10.1093/oxfordjournals.humrep.a138151.
6
Performance of cryopreserved pre-embryos obtained in in vitro fertilization cycles with or without a gonadotropin-releasing hormone agonist.在有或没有促性腺激素释放激素激动剂的体外受精周期中获得的冷冻保存胚胎的性能。
Fertil Steril. 1992 Mar;57(3):620-5. doi: 10.1016/s0015-0282(16)54910-3.
7
Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).一项关于体外受精-胚胎移植的前瞻性、随机、对照研究,比较单次剂量的促黄体生成素释放激素(LH-RH)拮抗剂(西曲瑞克)或LH-RH激动剂长效制剂(曲普瑞林)的效果。
Fertil Steril. 2000 Feb;73(2):314-20. doi: 10.1016/s0015-0282(99)00524-5.
8
Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).使用重组促卵泡激素(普丽康)和不同剂量促性腺激素释放激素拮抗剂加尼瑞克(奥加奴肽/拮抗剂)进行体外受精卵巢刺激期间多个卵泡发育的动态变化
Fertil Steril. 2001 Apr;75(4):688-93. doi: 10.1016/s0015-0282(00)01789-1.
9
Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.使用新型促性腺激素释放激素拮抗剂(西曲瑞克)恢复体外受精中的自然周期:一项最小刺激的试点研究
Hum Reprod. 1999 Mar;14(3):683-8. doi: 10.1093/humrep/14.3.683.
10
What is the best treatment for women with polycystic ovarian syndrome and high LH/FSH ratio? A comparison among in vitro fertilization with GnRH agonist, GnRH antagonist and in vitro maturation.对于多囊卵巢综合征且促黄体生成素/促卵泡生成素比值高的女性,最佳治疗方法是什么?GnRH激动剂、GnRH拮抗剂体外受精与体外成熟之间的比较。
J Endocrinol Invest. 2016 Jul;39(7):799-803. doi: 10.1007/s40618-015-0429-x. Epub 2016 Jan 21.

引用本文的文献

1
The quality of human eggs and its pre-IVF incubation.人类卵子的质量及其体外受精前培养
Reprod Med Biol. 2025 May 2;24(1):e12652. doi: 10.1002/rmb2.12652. eCollection 2025 Jan-Dec.
2
Agonist triggering in oocyte donation programs-Mini review.卵母细胞捐赠项目中的激动剂触发 - 综述。
Front Endocrinol (Lausanne). 2022 Aug 26;13:838236. doi: 10.3389/fendo.2022.838236. eCollection 2022.
3
Gonadotropin-releasing hormone agonist ovulation trigger-beyond OHSS prevention.促性腺激素释放激素激动剂诱发排卵——超越 OHSS 的预防。
Ups J Med Sci. 2020 May;125(2):138-143. doi: 10.1080/03009734.2020.1737599. Epub 2020 Mar 25.
4
Repeat Dose of Gonadotropin-releasing Hormone Agonist Trigger in Polycystic Ovarian Syndrome Undergoing Fertilization Cycles Provides a Better Cycle Outcome - A proof-of-concept Study.重复剂量促性腺激素释放激素激动剂扳机在接受体外受精周期的多囊卵巢综合征患者中可带来更好的周期结局——一项概念验证研究
J Hum Reprod Sci. 2017 Oct-Dec;10(4):271-280. doi: 10.4103/jhrs.JHRS_102_17.
5
A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.一种新的卵母细胞成熟触发方法,使用 1500IU 的人绒毛膜促性腺激素加 450IU 的卵泡刺激素,可能会降低所有体外受精刺激方案中的卵巢过度刺激综合征。
J Assist Reprod Genet. 2018 Feb;35(2):297-307. doi: 10.1007/s10815-017-1074-4. Epub 2017 Oct 30.
6
GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article.体外受精/卵胞浆内单精子注射周期中促性腺激素释放激素拮抗剂方案里促性腺激素释放激素激动剂扳机与绒毛膜促性腺激素扳机的比较:一篇综述文章
Int J Reprod Biomed. 2016 Sep;14(9):557-566.
7
Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study.促性腺激素释放激素激动剂与人绒毛膜促性腺激素双重触发对提高卵母细胞成熟率的评估:一项前瞻性随机研究。
J Hum Reprod Sci. 2016 Apr-Jun;9(2):101-6. doi: 10.4103/0974-1208.183506.
8
Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis.尽管采用了分段方法和卵巢过度刺激综合征预防措施,仍发生了早发性卵巢过度刺激综合征。
J Hum Reprod Sci. 2015 Oct-Dec;8(4):234-8. doi: 10.4103/0974-1208.170415.
9
Safety of drugs used in assisted reproduction techniques.辅助生殖技术中使用药物的安全性。
Drug Saf. 2005;28(6):513-28. doi: 10.2165/00002018-200528060-00004.
10
Endogenous LH surge versus hCG as ovulation trigger after low-dose highly purified FSH in IUI: a comparison of 761 cycles.低剂量高纯度促卵泡生成素(FSH)宫腔内人工授精(IUI)后,内源性促黄体生成素(LH)峰与绒毛膜促性腺激素(hCG)作为排卵触发剂的比较:761个周期的对比
J Assist Reprod Genet. 1997 Oct;14(9):518-24. doi: 10.1023/a:1021127410300.